Elanco Animal Health Inc (ELAN): Total Assets
$13.36B
As of 2025-12-31
$13.56B
As of 2026-06-30
-4.8%
3-year compound annual growth
-5.5%
5-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $13.36B | +5.9% | 2026-02-24, Balance as of period end |
| 2024-12-31 | $12.61B | -12.2% | 2026-02-24, Balance as of period end |
| 2023-12-31 | $14.36B | -7.3% | 2025-02-25, Balance as of period end |
| 2022-12-31 | $15.49B | -6.0% | 2024-02-26, Balance as of period end |
| 2021-12-31 | $16.48B | -6.9% | 2023-03-01, Balance as of period end |
| 2020-12-31 | $17.69B | +96.9% | 2022-02-28, Balance as of period end |
| 2019-12-31 | $8.99B | +0.3% | 2021-03-01, Balance as of period end |
| 2018-12-31 | $8.96B | +0.2% | 2020-02-28, Balance as of period end |
| 2017-12-31 | $8.94B | n/a | 2019-02-20, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Elanco Animal Health Inc (ELAN) | 2025-12-31 | $13.36B | +5.9% |
| Jazz Pharmaceuticals plc (JAZZ) | 2025-12-31 | $11.66B | -2.9% |
| Perrigo Co PLC (PRGO) | 2025-12-31 | $8.54B | -11.5% |
| BeOne Medicines Ltd. (ONC) | 2025-12-31 | $8.19B | +38.3% |
| Alnylam Pharmaceuticals, Inc. (ALNY) | 2025-12-31 | $4.97B | +17.1% |
| Organon & Co. (OGN) | 2025-12-31 | $12.87B | -1.8% |
| BioMarin Pharmaceutical Inc (BMRN) | 2025-12-31 | $7.59B | +8.7% |
| United Therapeutics Corp (UTHR) | 2025-12-31 | $7.88B | +7.0% |
| Amneal Pharmaceuticals, Inc. (AMRX) | 2025-12-31 | $3.68B | +5.1% |
Compare ELAN, JAZZ, PRGO, ONC side by side · Screen every company in Pharmaceutical Preparations ↗